GlobalData on MSN4mon
Biogen and Neomorph enter molecular glue degrader deal
Biogen and Neomorph have entered a research partnership aimed at discovering and developing molecular glue degraders for the ...
Hosted on MSN1mon
AbbVie and Neomorph link on oncology/immunology glue degraders
AbbVie and Neomorph are forming a partnership and option-to-license agreement to develop molecular glue degraders, aiming to introduce a new class of treatments across oncology and immunology.